Cargando…
The thromboembolic risk in covid-19 women under hormonal treatment group
Autores principales: | Ramírez, Isabel, De la Viuda, Esther, Baquedano, Laura, Coronado, Pluvio, Llaneza, Plácido, Mendoza, Nicolás, Otero, Borja, Sánchez, Sonia, Cancelo, Mª Jesús, Páramo, José Antonio, Cano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301135/ https://www.ncbi.nlm.nih.gov/pubmed/32565010 http://dx.doi.org/10.1016/j.maturitas.2020.05.021 |
Ejemplares similares
-
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia
por: Ramírez, Isabel, et al.
Publicado: (2020) -
Response to “Should estrogen be used in the co-treatment of COVID-19 patients?”
por: Cano, Antonio, et al.
Publicado: (2020) -
Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement
por: Coronado, Pluvio J., et al.
Publicado: (2021) -
Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review
por: Fiol, Gabriel, et al.
Publicado: (2023) -
Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report
por: Llaneza-Suarez, Cristina, et al.
Publicado: (2020)